Navigation Links
Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast

IRVINE, Calif., April 23 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) will announce results for the Company's fiscal third quarter of 2010 for the period ended March 31, 2010 on Thursday, April 29, 2010 after the market closes.

Following the release, Pro-Dex will conduct a conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss operating performance for the quarter.  Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call.  If you would like to join the call, domestic callers dial (866) 317-6010 and international callers dial (412) 317-6010, conference I.D. 440155.  You can identify the call as the Pro-Dex Third Quarter Earnings Call.  The call will also be broadcast live over the internet and may be accessed directly by visiting or by visiting the Company's website at  

For those who cannot access the live broadcast, a replay will be available from 2 hours after the call for 48 hours by dialing (877) 344-7529 for domestic callers or (412) 317-0088 for international callers, and entering conference I.D. number 440155.  An online archive of the broadcast will be available on the Company's website for 365 days.  

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.

For more information, visit the Company's website at

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
2. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
3. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
4. pHase Pharmaceuticals Announces New Venture
5. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
6. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
7. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
10. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
11. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
Post Your Comments:
(Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
(Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
(Date:12/1/2015)... YORK , Dec. 1, 2015 Relmada Therapeutics, ... the treatment of chronic pain, announced today that the company ... will be held December 1-3 at the Luxe Sunset Boulevard ... Sergio Traversa , CEO of Relmada Therapeutics, will present on ... Eastern Time). . Please register at least ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
(Date:11/30/2015)... NC (PRWEB) , ... November 30, 2015 , ... ... Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various categories ... These four influential figures make up an elite group of Gold Medal Moms ...
(Date:11/30/2015)... Islands, BWI (PRWEB) , ... December 01, 2015 , ... ... Recently Caribbean Journal, one of the leading digital news sites highlighting Caribbean destinations, has ... The weather. While much of North America shivers under chilly grey skies or ...
Breaking Medicine News(10 mins):